GaletaBio has brought together the world’s most advanced capabilities not only for producing next-generation genomic medicines but to deliver traditional drugs just to the appropriate cells.
Its founding team has decades of expertise across a full range of viral and non-viral delivery systems, types of therapeutic cargo, production methodologies, and analytical capabilities to enable high purity, high yield production.
From the earliest stages of development, GaletaBio and its partners can deploy its predictive biology system to help validate potential efficacy as well as optimize drug product design and formulation. GaletaBio’s services for precision genomic medicines – from minicircle DNA to all forms of RNA and targeted delivery systems – are designed to provide rapid, reliable solutions for innovators, developers, and investors.
Removing Barriers in Genomic Medicine and Targeted Delivery
Therapeutic Cargo
- pDNA
- mcDNA
- RNA
- Proteins
Delivery Systems
- VLPs
- LNPs
- Polymers
Development
- Predictive Biology
- Formulation
- Process & Analytics
- Tech Transfer
GMP Readiness
- GMP Suites
- Management Support
- Animal Testing Alternatives
- In-Kind Investment